Connection

John Wrangle to Humans

Back to Details
This is a "connection" page, showing publications John Wrangle has written about Humans.
John Wrangle
Connection Strength
0.284
Humans
  1. Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers. J Immunol. 2022 03 15; 208(6):1362-1370.
    View in: PubMed
    Score: 0.031
  2. Can We MIRror the Efficacy of Immune Checkpoints With miRNAs? J Thorac Oncol. 2020 11; 15(11):1703-1704.
    View in: PubMed
    Score: 0.028
  3. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol. 2018 05; 19(5):694-704.
    View in: PubMed
    Score: 0.023
  4. IL-2 and Beyond in Cancer Immunotherapy. J Interferon Cytokine Res. 2018 02; 38(2):45-68.
    View in: PubMed
    Score: 0.023
  5. Imaging in Advanced Non-Small Cell Lung Cancer: A Medical Oncology Perspective. J Thorac Imaging. 2016 Jul; 31(4):238-42.
    View in: PubMed
    Score: 0.021
  6. Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer. Clin Cancer Res. 2014 Apr 01; 20(7):1856-64.
    View in: PubMed
    Score: 0.018
  7. Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine. Oncotarget. 2013 Nov; 4(11):2067-79.
    View in: PubMed
    Score: 0.017
  8. Ha sentido sola? Culturally competent screening for intimate partner violence in Latina women. J Womens Health (Larchmt). 2008 Mar; 17(2):261-8.
    View in: PubMed
    Score: 0.012
  9. Chemoprevention of squamous cell carcinoma of the head and neck. Curr Opin Oncol. 2007 May; 19(3):180-7.
    View in: PubMed
    Score: 0.011
  10. Association of age with survival in older patients with cutaneous melanoma treated with immune checkpoint inhibitors. J Geriatr Oncol. 2022 09; 13(7):1003-1010.
    View in: PubMed
    Score: 0.008
  11. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.008
  12. DNA-methylation for the detection and distinction of 19 human malignancies. Epigenetics. 2022 Jan-Feb; 17(2):191-201.
    View in: PubMed
    Score: 0.007
  13. A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC. J Thorac Oncol. 2021 09; 16(9):1559-1569.
    View in: PubMed
    Score: 0.007
  14. Immune checkpoint inhibitors retain effectiveness in older patients with cutaneous metastatic melanoma. J Geriatr Oncol. 2021 04; 12(3):394-401.
    View in: PubMed
    Score: 0.007
  15. SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Sci Adv. 2019 09; 5(9):eaax6352.
    View in: PubMed
    Score: 0.006
  16. Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma. Clin Cancer Res. 2018 11 01; 24(21):5250-5260.
    View in: PubMed
    Score: 0.006
  17. The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine. Cancer. 2018 04 15; 124(8):1650-1659.
    View in: PubMed
    Score: 0.006
  18. First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. N Engl J Med. 2017 06 22; 376(25):2415-2426.
    View in: PubMed
    Score: 0.006
  19. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum. Clin Cancer Res. 2017 04 15; 23(8):1998-2005.
    View in: PubMed
    Score: 0.005
  20. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1068-74.
    View in: PubMed
    Score: 0.005
  21. Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer. Oncotarget. 2015 Jan 01; 6(1):56-70.
    View in: PubMed
    Score: 0.005
  22. Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol. 2015 Jan; 10(1 Suppl 1):S1-63.
    View in: PubMed
    Score: 0.005
  23. Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers. J Thorac Oncol. 2014 Jun; 9(6):752-9.
    View in: PubMed
    Score: 0.005
  24. Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. Clin Chim Acta. 2013 Oct 21; 425:169-75.
    View in: PubMed
    Score: 0.004
  25. CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA. J Infect Dis. 2012 Apr 01; 205(7):1095-9.
    View in: PubMed
    Score: 0.004
  26. Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer. Ann Thorac Surg. 2012 Feb; 93(2):405-12.
    View in: PubMed
    Score: 0.004
  27. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov. 2011 Dec; 1(7):598-607.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.